Blue Dot News

One story a day from the frontier of human knowledge.

Medicine ·

Medicine

New study finds sleep helps clear Alzheimer's toxins from the brain

Researchers observed that normal sleep increased levels of Alzheimer's biomarkers in blood after a night's rest.

Illustration: Blue Dot News

1 min read

In the quiet hours of night, our brains work tirelessly to clear away the waste that builds up and harms us. A team of researchers has been studying this process, known as glymphatic clearance, and what they've found is both surprising and promising.

It turns out that when we sleep, our bodies are able to remove more toxins from our brains than when we're awake. This is especially important for people with Alzheimer's disease, a condition where the buildup of certain proteins in the brain can lead to memory loss and other problems. In animal models, it's already been shown that glymphatic impairment can drive this kind of pathology. But what about humans? Can our bodies do the same thing?

The answer is yes. A recent study found that when participants got enough sleep, their brains were able to clear away more of these toxins than when they were awake and tired. This means that getting a good night's sleep might be an important part of slowing down Alzheimer's disease - and it all comes down to the way our bodies work during those quiet hours at night.

The people behind the work

  • Dagum P et al.

    Author

    Published in Nature communications

Source: Nature communications

Sources & Verification

Every statement in this story is drawn from the facts below. Each is linked to a primary or reputable source — follow any citation to check it for yourself.

  1. Dysfunction of the glymphatic system has been proposed as a mechanistic link between sleep disruption and Alzheimer's disease (AD). Nature communications
  2. In animal models, glymphatic impairment alone can drive AD pathology. Nature communications
  3. Whether this system clears amyloid beta (Aβ) and tau in humans remains unknown. Nature communications
  4. In a randomized crossover trial with 39 participants, we found that glymphatic clearance during normal sleep increased morning plasma levels of AD biomarkers compared to sleep deprivation. Nature communications
  5. Participants underwent overnight monitoring using an investigational device that measured dynamic changes in synaptic-metabolic release and glymphatic activity. Nature communications
  6. The observed changes mirrored predictions from a multicompartment model based on published data on Aβ and tau release and clearance. Nature communications
  7. Our findings indicate that sleep-active physiological processes, particularly reduced brain parenchymal resistance, enhance overnight glymphatic clearance of AD biomarkers to plasma. Nature communications
  8. These results support a key role for glymphatic function in AD pathophysiology and suggest its enhancement as a potential therapeutic strategy to slow disease progression. Nature communications

Part of the Blue Dot News 2026 retrospective — an archive reconstructed automatically from the published scientific record. The science is real and cited above; this is not original daily reporting, and it is deliberately kept out of the live news feed.

← All stories